The ZAP-X® Gyroscopic Radiosurgery® platform opens new frontiers in modern surgical robotics, bringing state-of-the-art cranial SRS to more patients in more places, and expanding world-class care to locations previously considered inconceivable.
As the first-in-kind “self-shielded” radiosurgery system, ZAP-X eliminates the need for high-cost radiation bunkers.*
Enabling simple department expansions, ZAP-X also makes cost-effective SRS feasible in virtually any location—including suburban and rural satellites, as well as innovative outpatient settings.
Using state-of-the-art linear accelerator technology, ZAP-X enables diverse non-coplanar radiation delivery while eliminating the historical need for live radioactive sources. No more costly source replacements. No more regulatory bureaucracy.
And as access to Co-60 becomes increasingly scarce, ZAP-X future-proofs your SRS investment.
ZAP-X is dedicated to world-class cranial radiosurgery without the quality trade-offs associated with multi-purpose, full-body radiotherapy systems.
Leveraging a unique dual independent gantry design, ZAP-X aims to maximally protect neurocognitive function and preserve the option for future potential SRS re-treatments.
As the creator of the first new dedicated radiosurgery platform in nearly half a century, ZAP enables neurosurgeons and radiation oncologists to change precision radiation medicine for the better.
Founded in 2014 by John R. Adler, Jr., MD, renowned Stanford neurosurgeon and inventor of the CyberKnife®, ZAP strives to define the future of radiosurgery through better technology and new potential clinical applications.
When treating the brain, the tools cannot be too refined. As a surgical alternative for select cranial indications, ZAP-X offers patients the latest technological advances in radiosurgery.
As a painless outpatient procedure with no incision, and often no recovery period, patients typically return to normal activities the same day as treatment.
Putting patients first, ZAP-X aspires to set new standards in care through a ground-up design dedicated to cranial SRS – without the design compromises necessary for multi-purpose systems to treat breast, lung, and prostate cancers.
The goal: best-in-class dosimetry with an exceptionally low non-therapeutic dose to the healthy brain and body.
Build a distinguished clinical brand with ZAP-X, a preeminent technology proven to yield significant publication, presentation, and media interest.
And by blending lower facility and operating costs with well-established reimbursement, ZAP-X introduces a new standard in cost-effective, high-quality care.